Clinical Trials Logo

Clinical Trial Summary

This study will explore the use of flortaucipir as a biomarker for chronic traumatic encephalopathy (CTE) and examine the relationship between clinical presentation and tau deposition.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02079766
Study type Interventional
Source Avid Radiopharmaceuticals
Contact
Status Completed
Phase Phase 2
Start date June 2014
Completion date October 2015

See also
  Status Clinical Trial Phase
Enrolling by invitation NCT03724136 - Alzheimer's Autism and Cognitive Impairment Stem Cell Treatment Study N/A
Recruiting NCT05235802 - Long-term Follow-up in Severe Traumatic Brain Injury
Recruiting NCT04928534 - Cohort Study of Blood Biomarkers for TES
Not yet recruiting NCT06254469 - Visualizing Brain Proteinopathies Using [F-18]Flornaptitril-PET in the Prediction of Clinical Progression of Mild Cognitive Impairment With Either Suspected Chronic Traumatic Encephalopathy or Alzheimer's Disease Phase 3
Recruiting NCT02795052 - Neurologic Stem Cell Treatment Study N/A
Recruiting NCT03218332 - Post-Concussion Syndrome in Professional Athletes: A Multidisciplinary Study
Completed NCT02266563 - Amyloid and Tauopathy PET Imaging in Acute and Chronic Traumatic Brain Injury
Completed NCT02191267 - Tau Imaging of Chronic Traumatic Encephalopathy Phase 2
Enrolling by invitation NCT04489082 - Near-Infrared Laser Stimulation for Various Neurological Conditions N/A
Active, not recruiting NCT05490576 - Tau And Connectomics In TES Study Phase 1
Recruiting NCT03944447 - Outcomes Mandate National Integration With Cannabis as Medicine Phase 2
Completed NCT02798185 - The DIAGNOSE-CTE Research Project